Individual Cognitive Stimulation Therapy for dementia
- Conditions
- Mental and Behavioural DisordersDementiaUnspecified dementia
- Registration Number
- ISRCTN65945963
- Lead Sponsor
- niversity College London (UCL) (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 306
1. Meet Diagnostic and Statistical Manual of Mental Disorders 4th edition (DSM IV) criteria for dementia
2. Score 10 or above on the Mini Mental State Examination (MMSE)
3. Some ability to communicate and understand
4. See/hear well enough to participate
5. No major physical illness or disability affecting their participation
6. Male or female, no age restrictions
Additional criteria will include living in the community and regular availability of a carer (or friend or befriender) to participate in the sessions.
People with dementia not meeting the criteria for individual work (living in a care home, no available family carer) but who are eligible for group CST will be linked up with the trial of maintenance group CST (NIHR programme).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Alzheimer's Disease Assessment Scale - Cognitive subscale (ADAS-Cog) (Rosen et al., 1984)<br>2. Quality of Life-Alzheimer's disease Scale (QoL-AD) (Logsdon et al., 1999)<br>3. Short Form-12 (SF-12) (Ware, Kosinski, and Keller, 1996)<br>Assessments will take place at baseline (pre iCST), 13 weeks (to safeguard loss to follow-up) and 26 weeks.
- Secondary Outcome Measures
Name Time Method 1. Client Service Receipt Inventory (Beecham & Knapp, 1992)<br>2. Dementia-related Quality of Life (DEMQOL) (Smith et al., 2005)<br>3. Behaviour<br>4. Neuropsychiatric Inventory (NPI) (Cummings et al. 1994)<br>5. Bristol Activities of Daily Living Scale (BADLS) (Bucks et al, 1996)<br>6. Hospital Anxiety and Depression Scale (HADS) (Zigmond and Snaith, 1983)<br>7. EQ-5D (EuroQol group, 1990)<br>Assessments will take place at baseline, 13 and 26 weeks.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.